Bonesupport Holding

Declaration of Voting Results & Voting Rights Announcements • Jul 31, 2024

CHANGE IN NUMBER OF SHARES AND VOTES IN BONESUPPORT HOLDING AB (PUBL)

BONESUPPORT HOLDING AB (publ), a leading company in orthobiologics for the management of bone injuries, today announced a change in the number of shares and votes.

As per July 31, 2024, the total number of shares in BONESUPPORT HOLDING AB (publ) amounts to 66,692,350, divided into 65,787,195 ordinary shares with one vote per share and 905,155 series C shares with one-tenth of a vote per share, corresponding to a total of 65,877,710.5 votes.

The change in number of shares and votes is due partly to the conversion of 60,000 series C shares, which previously have been issued and repurchased within the context of the Company's share saving programs, into ordinary shares during the month of July, and partly to the exercise of 30,000 warrants within the company's employee stock options programs. The number of ordinary shares has thus increased by 66,000 and the number of series C-shares has decreased by 60,000 shares. Following the conversion and exercise, the number of votes has increased by 60,000.

For more information contact:

BONESUPPORT AB Emil Billbäck, CEO +46 (0) 46 286 53 70

Håkan Johansson, CFO +46 (0) 46 286 53 70 ir@bonesupport.com

Cord Communications Charlotte Stjerngren +46 (0) 708 76 87 87 charlotte.stjerngren@cordcom.se www.cordcom.se

This information is information that BONESUPPORT Holding AB (publ) is obliged to make public pursuant to the Financial Instruments Trading Act. The information was submitted for publication at 2024-07-31 08:00 CEST.

Press Release 31 July 2024 08:00:00 CEST

About BONESUPPORT™

BONESUPPORT (Nasdaq Stockholm: BONEX) develops and commercializes innovative injectable bio-ceramic bone graft substitutes that remodel to the patient's own bone and have the capability of eluting drugs. BONESUPPORT's bone graft substitutes are based on the patented technology platform CERAMENT. The company is conducting several clinical studies to further demonstrate the clinical and health economic benefits its products deliver. The company is based in Lund, Sweden, and the net sales amounted to SEK 591 million in 2023. Please visit www.bonesupport. com for more information.

BONESUPPORT and CERAMENT are registered trademarks of BONESUPPORT AB.

Attachments

CHANGE IN NUMBER OF SHARES AND VOTES IN BONESUPPORT HOLDING AB (PUBL)